Comparison 10. Subgroup analysis: female versus male for the comparison of high‐dose dexamethasone (12 mg or higher) versus low‐dose dexamethasone (6 mg to 8mg) for hospitalised individuals with a confirmed diagnosis of symptomatic COVID‐19.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
10.1 All‐cause mortality up to 30 days	2	1069	Risk Ratio (M‐H, Random, 95% CI)	0.87 [0.72, 1.04]
10.1.1 Female	2	333	Risk Ratio (M‐H, Random, 95% CI)	0.89 [0.65, 1.22]
10.1.2 Male	2	736	Risk Ratio (M‐H, Random, 95% CI)	0.91 [0.62, 1.34]
10.2 All‐cause mortality up to 120 days	2	1066	Risk Ratio (M‐H, Random, 95% CI)	0.87 [0.74, 1.02]
10.2.1 Female	2	333	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.70, 1.23]
10.2.2 Male	2	733	Risk Ratio (M‐H, Random, 95% CI)	0.85 [0.70, 1.03]